Context Deferred Long Term Liab vs Cash Analysis
| CNTX Stock | USD 1.52 0.02 1.33% |
Context Therapeutics financial indicator trend analysis is way more than just evaluating Context Therapeutics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Context Therapeutics is a good investment. Please check the relationship between Context Therapeutics Deferred Long Term Liab and its Cash accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Context Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Context Stock please use our How to Invest in Context Therapeutics guide.
Deferred Long Term Liab vs Cash
Deferred Long Term Liab vs Cash Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Context Therapeutics Deferred Long Term Liab account and Cash. At this time, the significance of the direction appears to have almost no relationship.
The correlation between Context Therapeutics' Deferred Long Term Liab and Cash is 0.14. Overlapping area represents the amount of variation of Deferred Long Term Liab that can explain the historical movement of Cash in the same time period over historical financial statements of Context Therapeutics, assuming nothing else is changed. The correlation between historical values of Context Therapeutics' Deferred Long Term Liab and Cash is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Deferred Long Term Liab of Context Therapeutics are associated (or correlated) with its Cash. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash has no effect on the direction of Deferred Long Term Liab i.e., Context Therapeutics' Deferred Long Term Liab and Cash go up and down completely randomly.
Correlation Coefficient | 0.14 |
| Relationship Direction | Positive |
| Relationship Strength | Insignificant |
Deferred Long Term Liab
Liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue.Cash
Cash refers to the most liquid asset of Context Therapeutics, which is listed under current asset account on Context Therapeutics balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Context Therapeutics customers. The amounts must be unrestricted with restricted cash listed in a different Context Therapeutics account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.Most indicators from Context Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Context Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Context Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Context Stock please use our How to Invest in Context Therapeutics guide.Selling General Administrative is likely to rise to about 9.1 M in 2024, whereas Issuance Of Capital Stock is likely to drop slightly above 31 M in 2024.
Context Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Context Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Context Stock Analysis
When running Context Therapeutics' price analysis, check to measure Context Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Context Therapeutics is operating at the current time. Most of Context Therapeutics' value examination focuses on studying past and present price action to predict the probability of Context Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Context Therapeutics' price. Additionally, you may evaluate how the addition of Context Therapeutics to your portfolios can decrease your overall portfolio volatility.